“‘Clearly in the test tube cannabinoids have the ability to block at least one of the probable causal mechanisms in Alzheimer’s disease and so become a potential treatment or preventative agent that needs to be tested in humans.”

Dr Richard Harvey, research director of the Alzheimer’s Society

Read more: http://www.alzheimers.org.uk/site/scripts/news_article.php?newsID=123